Biocytogen Closes $79M Series D Funding
On August 2019, Beijing Biocytogen Co., Ltd. ("Biocytogen") announced the closing of its Series D funding of $79M (RMB 543M). This round of financing was…
Read more
Symposium: Future of Biologic Drug Discovery and Development
Free to attend, lunch and light dinner will be provided. Join Biocytogen to learn more about the cutting-edge technologies and latest research in biologic drug. The…
Read more
Biocytogen at the ESMO 2018 Annual Meeting
Biocytogen at the at the ESMO 2018 annual meeting, which will take place in Munich, Germany from between 19-23 October 2018.
Read more
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University
Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and…
Read more
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019
American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019, with a theme of “Integrative…
Read more
American Association for Cancer Research (AACR) Annual Meeting 2019
Biocytogen Highlights 10 Posters highlight new IO targets (e.g. CTLA-4, OX40, CD3e), preclinical services, PK/PD studies, and antibody screening platform will be presented at AACR.…
Read more
Former Swedish Prime Minister Visits Biocytogen
Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler…
Read more
Biocytogen at the at the European Society for Medical Oncology (ESMO) 2018 annual meeting
Biocytogen is excited to exhibit at the European Society for Medical Oncology (ESMO) 2018 annual meeting, which will take place in Munich, Germany from between…
Read more
Biocytogen seminar at the University of Western Ontario
Dr. James Jin, the Vice President of Biocytogen, will hold a seminar at the University of Western Ontario in London, Canada. This seminar mainly focuses…
Read more
Biocytogen seminar at University of Toronto
Dr. James Jin, the Vice President of Biocytogen, will hold a seminar at the University of Toronto. This seminar mainly focuses on CRISPR/Cas9 based Extreme…
Read more